Professional Compounding Centers of America

Professional Compounding Centers of America (PCCA) is a Houston-based organization that supplies independent compounding pharmacies with bulk pharmaceutical ingredients, equipment, training, and formulation support. It does not dispense medications directly to patients but instead serves as a behind-the-scenes resource for the pharmacists who do. In WellRank's latest AI-answer index, PCCA ranks 14th in the Compounded GLP-1s category with 8% visibility, and the single mention in WellRank's corpus carries a positive tone.

PCCA, accessible at pccarx.com, is a membership-based organization founded to support independent compounding pharmacies across North America and beyond. Its core business model combines the sale of high-quality active pharmaceutical ingredients and bases with education, regulatory guidance, and technical consulting. Rather than operating as a pharmacy itself, PCCA functions as a wholesale supplier and professional network that helps member pharmacies compound medications safely and compliantly.

• Bulk active pharmaceutical ingredients (APIs) for compounding, including hormone and specialty compounds
• Proprietary compounding bases and delivery vehicles designed for consistent formulations
• Comprehensive training programs and continuing education for compounding pharmacists
• Regulatory and compliance support to help member pharmacies navigate USP standards and state board requirements
• Technical consulting and formulation development assistance
• Member network resources including marketing tools and business support for independent pharmacies

PCCA primarily serves independent compounding pharmacies and the pharmacists who operate them across the United States, Canada, and select international markets. Its resources are relevant to pharmacies that compound for a wide range of therapeutic areas including hormone replacement therapy, dermatology, pain management, veterinary medicine, and, increasingly, weight management compounds such as GLP-1 related formulations.

• An independent compounding pharmacist seeking a reliable API supplier and formulation guidance to expand their menu of personalized medications.
• A pharmacy owner looking for membership-based business support, compliance tools, and continuing education to stay current with evolving USP regulations.
• A clinical pharmacist at a specialty practice who needs custom dosage forms not available through commercial manufacturers.
• A veterinary compounding pharmacist requiring animal-specific bases and species-appropriate formulation expertise.

PCCA is a privately held company; funding details, ownership structure, and financial performance are not publicly disclosed.

PCCA has drawn increased attention in the context of compounded GLP-1 medications, as demand for semaglutide and tirzepatide compounds has grown substantially among independent pharmacies. The organization has been active in providing member pharmacies with formulation guidance and regulatory clarity as the FDA and state boards have continued to update their positions on compounded GLP-1 products. PCCA has historically been engaged in advocacy efforts related to the compounding industry, and that role has become more prominent as the regulatory environment around these high-profile compounds evolves.

Based on WellRank's corpus, the single AI mention of PCCA in the Compounded GLP-1s category is positive, with no neutral or mixed mentions recorded. This limited but favorable signal suggests AI engines currently frame PCCA as a credible industry resource when the topic arises, though its relatively low visibility rank of 14th with 8% share indicates it is not yet a primary reference in AI-generated answers on this subject.

PCCA operates on a membership model for pharmacies, with product pricing tied to API quantities and formulation supplies purchased by member pharmacies. Specific membership fees and ingredient pricing are not published publicly and vary based on membership tier and order volume.